Search research articles
Contact Us
Filters
Showing results (131-140 of 160) with videos related to
Page
of 16
Sort By:
Journal of the International Society of Sports Nutrition
|
November 17, 2020
Acute and chronic effects of Rhaponticum carthamoides and Rhodiola rosea extracts supplementation coupled to resistance exercise on muscle protein synthesis and mechanical power in rats
Rémi Roumanille, Barbara Vernus, Thomas Brioche, et al.
Journal of Virology
|
May 14, 2026
Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins
Dorine Martres, Théo Montagné, Sandra Pani, et al.
The Journal of Antimicrobial Chemotherapy
|
June 16, 2018
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study
Minh P Lê, Marie-Laure Chaix, Sylvie Chevret, et al.
The Journal of Clinical Investigation
|
December 14, 2011
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals
Maud Mavigner, Michelle Cazabat, Martine Dubois, et al.
AIDS (London, England)
|
November 26, 2019
Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection
Raphael Veil, Isabelle Poizot-Martin, Jacques Reynes, et al.
Andrology
|
August 2, 2024
Mild coronavirus disease 2019: Results of a multicentric prospective study on severe acute respiratory syndrome coronavirus 2 presence in semen fractions and cells and its effects on semen parameters
Louis Bujan, Gabriela Mendeluk, Dominique Mahé, et al.
The Journal of Antimicrobial Chemotherapy
|
November 4, 2025
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study
Romain Palich, Jade Ghosn, Karine Lacombe, et al.
AIDS (London, England)
|
October 17, 2018
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial
Romain Palich, Jade Ghosn, Antoine Chaillon, et al.
Frontiers in Physiology
|
March 3, 2020
Evaluation of an Antioxidant and Anti-inflammatory Cocktail Against Human Hypoactivity-Induced Skeletal Muscle Deconditioning
Coralie Arc-Chagnaud, Guillaume Py, Théo Fovet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 17, 2024
Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection
Antoine Bachelard, Quentin Le Hingrat, Valentine-Marie Ferré, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 160) with videos related to
Sort By:
Page
of 16
Journal of the International Society of Sports Nutrition
|
November 17, 2020
Acute and chronic effects of Rhaponticum carthamoides and Rhodiola rosea extracts supplementation coupled to resistance exercise on muscle protein synthesis and mechanical power in rats
Rémi Roumanille, Barbara Vernus, Thomas Brioche, et al.
Journal of Virology
|
May 14, 2026
Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins
Dorine Martres, Théo Montagné, Sandra Pani, et al.
The Journal of Antimicrobial Chemotherapy
|
June 16, 2018
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study
Minh P Lê, Marie-Laure Chaix, Sylvie Chevret, et al.
The Journal of Clinical Investigation
|
December 14, 2011
Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals
Maud Mavigner, Michelle Cazabat, Martine Dubois, et al.
AIDS (London, England)
|
November 26, 2019
Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection
Raphael Veil, Isabelle Poizot-Martin, Jacques Reynes, et al.
Andrology
|
August 2, 2024
Mild coronavirus disease 2019: Results of a multicentric prospective study on severe acute respiratory syndrome coronavirus 2 presence in semen fractions and cells and its effects on semen parameters
Louis Bujan, Gabriela Mendeluk, Dominique Mahé, et al.
The Journal of Antimicrobial Chemotherapy
|
November 4, 2025
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study
Romain Palich, Jade Ghosn, Karine Lacombe, et al.
AIDS (London, England)
|
October 17, 2018
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial
Romain Palich, Jade Ghosn, Antoine Chaillon, et al.
Frontiers in Physiology
|
March 3, 2020
Evaluation of an Antioxidant and Anti-inflammatory Cocktail Against Human Hypoactivity-Induced Skeletal Muscle Deconditioning
Coralie Arc-Chagnaud, Guillaume Py, Théo Fovet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 17, 2024
Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection
Antoine Bachelard, Quentin Le Hingrat, Valentine-Marie Ferré, et al.
Page
of 16